Author Affiliations: Division of Cardiology, Department of Medicine, and Department of Cellular and Molecular Medicine, the Johns Hopkins University, Baltimore, Maryland.
In the United States and some other parts of the world, the last half of the 20th century was a time to bask in the sunshine of substantial reductions in the mortality from heart disease and stroke. These trends were a result of both an improvement in acute treatment of cardiovascular disease (CVD) and public health–driven improvement in risk factors for CVD.1 Despite this progress, contemporary global trends raise new concerns. Acute treatment of heart disease and stroke continues to improve, but it has been unable to stem the tide of adverse trends in health factors that are already beginning to slow and reverse the declines in morbidity and mortality from CVD and stroke.2 Projections of the incidence, prevalence, and cost of CVD are alarming3 and have stirred action in the United States and around the world.
Tomaselli GF. Prevention of Cardiovascular Disease and StrokeMeeting the Challenge. JAMA. 2011;306(19):2147-2148. doi:10.1001/jama.2011.1668